Aimei Health Technology C... (AFJK)
Aimei Health Technology Co. Ltd Statistics
Share Statistics
Aimei Health Technology Co. Ltd has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 2.28K, so 0.03% of the outstanding shares have been sold short.
| Short Interest | 2.28K |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 0.22 |
Valuation Ratios
The PE ratio is 534.54 and the forward PE ratio is null. Aimei Health Technology Co. Ltd's PEG ratio is undefined.
| PE Ratio | 534.54 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 1.31 |
| P/FCF Ratio | 0 |
| PEG Ratio | undefined |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aimei Health Technology Co. Ltd.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.38, with a Debt / Equity ratio of 0.
| Current Ratio | 23.38 |
| Quick Ratio | 23.38 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is 0%.
| Return on Equity (ROE) | 0% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | 0% |
| Revenue Per Employee | $undefined |
| Profits Per Employee | $undefined |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 171.39K |
| Effective Tax Rate | 1 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Aimei Health Technology Co. Ltd's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 10.69 |
| 200-Day Moving Average | 10.49 |
| Relative Strength Index (RSI) | 55.81 |
| Average Volume (20 Days) | - |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -28.46K |
| Net Income | 171.39K |
| EBITDA | 171.39K |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 580.72K in cash and 0 in debt, giving a net cash position of 580.72K.
| Cash & Cash Equivalents | 580.72K |
| Total Debt | 0 |
| Net Cash | 580.72K |
| Retained Earnings | -134.34K |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0.
| Operating Cash Flow | 0 |
| Capital Expenditures | 0 |
| Free Cash Flow | 0 |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AFJK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for AFJK.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |